QA: Tenax Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2018_Tenax_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000034956, Tenax Therapeutics INC

  xvar xval
0 AssetsCurrent 8,062,893
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,945
3 remainder_Assets 1,817,863
4 LiabilitiesCurrent 1,008,840
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,762,201
9 ResearchAndDevelopmentExpense 10,632,390
10 remainder_Expenses 24,572,672
11 remainder_Revenues 0
12 remainder_NetIncome 443,980
13 remainder_ComprehensiveNetIncome 67,167,526
  yvar yval
0 Assets 9,890,701
1 Liabilities 1,008,840
2 Expenses 40,967,263
3 Revenues 0
4 StockholdersEquity 8,881,861
5 NetIncome -40,523,283
6 ComprehensiveNetIncome -6,939,520
7 BaseVar 59,739,155
8 EconomicCapitalRatiobeforeLimitedLiability 2.28
9 EconomicCapitalRatio 3.21

Edgar->Model Mapping

Feature Distribution

Change over Time